Javascript must be enabled to continue!
Formulation and Evaluation of Trimetazidine Hydrochloride Loaded Solid Lipid Nanoparticles
View through CrossRef
Objective The aim of the current study was to design trimetazidine hydrochloride solid lipid nano-particles SLNs and to evaluate them.Methods Hot homogenization technique was used for preparation of trimetazidine hydrochloride SLNs using different lipids Tristearin GMS and Compritol soy lecithin as stabilizers and Tween 80 Poloxamer as surfactants. Results The nano-particles were characterized for particle size polydispersity index PDI zeta potential entrapment efficiency and drug release patterns. Particle sizes ranged from 145.6 to 780.1 nm. All formulations showed PDI from 0.170 to 0.358. The zeta potential ranged from -24.2 to -38.0 mV trimetazidine SLNs demonstrated entrapment efficiency ranging from 84.42 to 93.82. The cumulative percentage release of drug from different trimetazidine hydrochloride nano- particles ranged from 75.43 to 93.59 depending upon nature and quantity of lipid used. Conclusion Among all the formulations F1 showed highest drug release of 93.59 and was considered as optimized formulation. Drug release was found to follow first order diffusion control and the lsquonrsquo value obtained from the Korsmeyer Pepparsquos model indicated anomalous diffusion non-Fickian type n value of F1 was 0.5716 as release mechanism. The particle size PDI and zeta potential of optimized formulation were found to be 153.8 nm 0.358 -38.0 mV respectively.
Rajiv Gandhi University of Health Sciences
Title: Formulation and Evaluation of Trimetazidine Hydrochloride Loaded Solid Lipid Nanoparticles
Description:
Objective The aim of the current study was to design trimetazidine hydrochloride solid lipid nano-particles SLNs and to evaluate them.
Methods Hot homogenization technique was used for preparation of trimetazidine hydrochloride SLNs using different lipids Tristearin GMS and Compritol soy lecithin as stabilizers and Tween 80 Poloxamer as surfactants.
Results The nano-particles were characterized for particle size polydispersity index PDI zeta potential entrapment efficiency and drug release patterns.
Particle sizes ranged from 145.
6 to 780.
1 nm.
All formulations showed PDI from 0.
170 to 0.
358.
The zeta potential ranged from -24.
2 to -38.
0 mV trimetazidine SLNs demonstrated entrapment efficiency ranging from 84.
42 to 93.
82.
The cumulative percentage release of drug from different trimetazidine hydrochloride nano- particles ranged from 75.
43 to 93.
59 depending upon nature and quantity of lipid used.
Conclusion Among all the formulations F1 showed highest drug release of 93.
59 and was considered as optimized formulation.
Drug release was found to follow first order diffusion control and the lsquonrsquo value obtained from the Korsmeyer Pepparsquos model indicated anomalous diffusion non-Fickian type n value of F1 was 0.
5716 as release mechanism.
The particle size PDI and zeta potential of optimized formulation were found to be 153.
8 nm 0.
358 -38.
0 mV respectively.
Related Results
GW24-e1192 The Effect of Trimetazidine on endothelial function of Patient with Chronic Heart Failure
GW24-e1192 The Effect of Trimetazidine on endothelial function of Patient with Chronic Heart Failure
Objectives
To observe the effect of the Trimetazidine on endothelial function of patient with chronic heart failure, in order to provide a theretical basis for cl...
Effect of trimetazidine on left ventricular functions and cardiac biomarkers in diabetic patients with left ventricular diastolic dysfunction: a randomized controlled trial
Effect of trimetazidine on left ventricular functions and cardiac biomarkers in diabetic patients with left ventricular diastolic dysfunction: a randomized controlled trial
Abstract
We investigated the impact of trimetazidine treatment on left ventricular (LV) functions and cardiac biomarkers in diabetic patients with diastolic dysfunction a...
Comparative evaluation of encapsulation efficiency, controlled release and antibacterial activity of edible nanoformulations against enteropathogens
Comparative evaluation of encapsulation efficiency, controlled release and antibacterial activity of edible nanoformulations against enteropathogens
Nanoencapsulation is an effective strategy to enhance the stability, delivery efficiency and biological activity of bioactive compounds. In the present study, three edible nanoform...
Role of Trimetazidine in Ameliorating Endothelial Dysfunction: A Review
Role of Trimetazidine in Ameliorating Endothelial Dysfunction: A Review
Endothelial dysfunction is a hallmark of cardiovascular diseases, contributing to impaired vasodilation, altered hemodynamics, and atherosclerosis progression. Trimetazidine, tradi...
An open-label Phase 2a study to assess the safety and tolerability of trimetazidine in patients with amyotrophic lateral sclerosis
An open-label Phase 2a study to assess the safety and tolerability of trimetazidine in patients with amyotrophic lateral sclerosis
Abstract
Metabolic imbalance is associated with amyotrophic lateral sclerosis progression. Impaired glucose oxidation and increased reliance on fatty acid oxidation ...
Central Composite Design for Formulation and Optimization of Solid Lipid Nanoparticles to Enhance Oral Bioavailability of Acyclovir
Central Composite Design for Formulation and Optimization of Solid Lipid Nanoparticles to Enhance Oral Bioavailability of Acyclovir
Treatment of herpes simplex infection requires high and frequent doses of oral acyclovir to attain its maximum therapeutic effect. The current therapeutic regimen of acyclovir is k...
Trimetazidine–Profen Hybrid Molecules: Synthesis, Chemical Characterization, and Biological Evaluation of Their Racemates
Trimetazidine–Profen Hybrid Molecules: Synthesis, Chemical Characterization, and Biological Evaluation of Their Racemates
Background: Trimetazidine is a clinically established cardioprotective agent with anti-ischemic and antioxidant properties, widely used in the management of coronary artery disease...
Design, Optimization, and In vitro Evaluation of Gentamicin Sulfateloaded Solid Lipid Nanoparticles for Ocular Administration
Design, Optimization, and In vitro Evaluation of Gentamicin Sulfateloaded Solid Lipid Nanoparticles for Ocular Administration
Background:
The current study set out to formulate, Design, and assess Solid Lipid Nanoparticles
(SLNs) loaded with Gentamicin sulfate.
Methods:
Glyceryl monostearate (GMS) was u...

